Taken together, our results demonstrated that BBR could inhibit the hepatoma cell growth with or without infectious HCV RNA replication, and that combining BBR with an autophagy inhibitor, such as BAF, could be an attractive strategy for the treatment of HCC. Here, BANF1 is linked to hepatocellular carcinoma.